DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Sulindac (Sulindac) - Side Effects and Adverse Reactions

 
 



ADVERSE REACTIONS

The following adverse reactions were reported in clinical trials or have been reported since the drug was marketed. The probability exists of a causal relationship between sulindac and these adverse reactions. The adverse reactions which have been observed in clinical trials encompass observations in 1,865 patients, including 232 observed for at least 48 weeks.

Incidence Greater Than 1%
Gastrointestinal
The most frequent types of adverse reactions occurring with sulindac are gastrointestinal; these include gastrointestinal pain (10%), dyspepsia**, nausea** with or without vomiting, diarrhea**, constipation**, flatulence, anorexia and gastrointestinal cramps.

Dermatologic
Rash**, pruritus.

Central Nervous System
Dizziness**, headache**, nervousness.

Special Senses
Tinnitus.

Miscellaneous
Edema (see WARNINGS).

Incidence Less Than 1 in 100
Gastrointestinal
Gastritis, gastroenteritis or colitis. Peptic ulcer and gastrointestinal bleeding have been reported. GI perforation and intestinal strictures (diaphragms) have been reported rarely.

Liver function abnormalities; jaundice, sometimes with fever; cholestasis; hepatitis; hepatic failure.

There have been rare reports of sulindac metabolites in common bile duct "sludge" and in biliary calculi in patients with symptoms of cholecystitis who underwent a cholecystectomy.

Pancreatitis (see PRECAUTIONS).

Ageusia; glossitis.

Dermatologic
Stomatitis, sore or dry mucous membranes, alopecia, photosensitivity.

Erythema multiforme, toxic epidermal necrolysis, Stevens-Johnson syndrome, and exfoliative dermatitis have been reported.

Cardiovascular
Congestive heart failure, especially in patients with marginal cardiac function; palpitation; hypertension.

Hematologic
Thrombocytopenia; ecchymosis; purpura; leukopenia; agranulocytosis; neutropenia; bone marrow depression, including aplastic anemia; hemolytic anemia; increased prothrombin time in patients on oral anticoagulants (see PRECAUTIONS).

Genitourinary
Urine discoloration; dysuria; vaginal bleeding; hematuria; proteinuria; crystalluria; renal impairment, including renal failure; interstitial nephritis; nephrotic syndrome.

Renal calculi containing sulindac metabolites have been observed rarely.

Metabolic
Hyperkalemia.

Musculoskeletal
Muscle weakness.

Psychiatric
Depression; psychic disturbances including acute psychosis.

Nervous System
Vertigo; insomnia; somnolence; paresthesia; convulsions; syncope; aseptic meningitis (especially in patients with systemic lupus erythematosus (SLE) and mixed connective tissue disease, see PRECAUTIONS).

Special Senses
Blurred vision; visual disturbances; decreased hearing; metallic or bitter taste.

Respiratory
Epistaxis.

Hypersensitivity Reactions
Anaphylaxis; angioneurotic edema; urticaria; bronchial spasm; dyspnea.
Hypersensitivity vasculitis.

A potentially fatal apparent hypersensitivity syndrome has been reported. This syndrome may include constitutional symptoms (fever, chills, diaphoresis, flushing), cutaneous findings (rash or other dermatologic reactions — see above), conjunctivitis, involvement of major organs (changes in liver function including hepatic failure, jaundice, pancreatitis, pneumonitis with or without pleural effusion, leukopenia, leukocytosis, eosinophilia, disseminated intravascular coagulation, anemia, renal impairment, including renal failure), and other less specific findings (adenitis, arthralgia, arthritis, myalgia, fatigue, malaise, hypotension, chest pain, tachycardia).

Causal Relationship Unknown
A rare occurrence of fulminant necrotizing fasciitis, particularly in association with Group A β-hemolytic streptococcus, has been described in persons treated with non-steroidal anti-inflammatory agents, sometimes with fatal outcome (see also PRECAUTIONS , General ).

Other reactions have been reported in clinical trials or since the drug was marketed, but occurred under circumstances where a causal relationship could not be established. However, in these rarely reported events, that possibility cannot be excluded. Therefore, these observations are listed to serve as alerting information to physicians.

Cardiovascular
Arrhythmia.

Metabolic
Hyperglycemia.

Nervous System
Neuritis.

Special Senses
Disturbances of the retina and its vasculature.

Miscellaneous
Gynecomastia.

MANAGEMENT OF OVERDOSAGE

Cases of overdosage have been reported and rarely, deaths have occurred. The following signs and symptoms may be observed following overdosage: stupor, coma, diminished urine output and hypotension.

In the event of overdosage, the stomach should be emptied by inducing vomiting or by gastric lavage, and the patient carefully observed and given symptomatic and supportive treatment.

Animal studies show that absorption is decreased by the prompt administration of activated charcoal and excretion is enhanced by alkalinization of the urine.



REPORTS OF SUSPECTED SULINDAC SIDE EFFECTS / ADVERSE REACTIONS

Below is a sample of reports where side effects / adverse reactions may be related to Sulindac. The information is not vetted and should not be considered as verified clinical evidence.

Possible Sulindac side effects / adverse reactions in 64 year old male

Reported by a pharmacist from United States on 2011-10-18

Patient: 64 year old male weighing 87.9 kg (193.4 pounds)

Reactions: Gastric Haemorrhage

Adverse event resulted in: hospitalization

Suspect drug(s):
Sulindac



Possible Sulindac side effects / adverse reactions in 54 year old male

Reported by a physician from United States on 2011-12-29

Patient: 54 year old male

Reactions: Death, Respiratory Arrest, Cardiac Arrest

Adverse event resulted in: death

Suspect drug(s):
Duloxetine Hydrochloride
    Dosage: unk
    Administration route: Oral

Methadone HCL
    Dosage: unk
    Administration route: Oral

Cyclobenzaprine HCL
    Dosage: unk
    Administration route: Oral

Alprazolam
    Dosage: unk
    Administration route: Oral

Sulindac
    Dosage: unk
    Administration route: Oral



Possible Sulindac side effects / adverse reactions in 54 year old male

Reported by a physician from United States on 2012-01-05

Patient: 54 year old male

Reactions: Death, Cardio-Respiratory Arrest, Respiratory Arrest, Toxicity TO Various Agents, Cardiac Arrest

Adverse event resulted in: death

Suspect drug(s):
Methadone HCL
    Dosage: unk, unknown
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Cyclobenzaprine
    Dosage: unk, unknown
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Alprazolam
    Dosage: unk, unknown
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Sulindac
    Dosage: unk, unknown
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Duloxetime Hydrochloride
    Dosage: unk, unknown
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



See index of all Sulindac side effect reports >>

Drug label data at the top of this Page last updated: 2010-04-13

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017